Welcome to our dedicated page for Cbd Life Science news (Ticker: CBDL), a resource for investors and traders seeking the latest updates and insights on Cbd Life Science stock.
CBD Life Sciences Inc. develops and distributes CBD, hemp-derived and wellness products through its flagship brand, The CBD Vault. The company's announcements cover product launches across therapeutic topicals, transdermal CBD patches, nicotine-free CBD pouches, edibles, functional mushroom supplements, nutraceutical powders, alkaline CBD functional water, and animal wellness products.
Recurring updates also address retail, wholesale, and online distribution, including specialty retail and dispensary placements, as well as brand expansion under wholly owned subsidiaries Mushroom Madness Inc. and Formrunner Apparel. The company links new formulations and distribution relationships to its broader CBD and functional wellness portfolio.
CBD Life Sciences (OTC PINK:CBDL) announced its entry into the Kosher Market through its subsidiary, LBC Bioscience Inc. The company plans to introduce products such as CBD Gummies, CBD Mints, and CBD Enriched Tea. CEO Lisa Nelson highlighted a growing customer demand for kosher products, which aims to expand their market reach significantly. Kosher certification is a rising trend in the food industry, with the kosher market valued at $17 billion and growing at an annual rate of 15%. CBD Life Sciences is also exploring cultivation sites in Arizona's expanding recreational cannabis market.
CBD Life Sciences (OTC PINK:CBDL) announced significant corporate developments, including the grand opening of its 2nd retail location and a distribution center in March 2021. A potential 3rd location in Sedona is also planned. The company introduced a vending machine for product sales in a convenience store. President & CEO Lisa Nelson reported outstanding early-year revenue and teased five new product launches, with plans to sell on Amazon. The firm is pursuing new cultivation opportunities in Arizona's recreational cannabis market.
CBD Life Sciences (OTC PINK:CBDL) announced the launch of a new hemp skincare line through its subsidiary, LBC Bioscience Inc. The lineup includes five products: Lavender & Chamomile Toner, Hyaluronic Acid Anti-Aging Serum, Vitamin C Brightening Creme, Nourishing Eye Creme, and Green Tea Facial Cleanser. CEO Lisa Nelson expressed optimism about expanding into retail locations and possibly QVC. CBD's benefits for skin health were emphasized, highlighting its moisturizing properties and anti-aging effects.
CBD Life Sciences (OTC PINK: CBDL) is in the final stages of launching its hemp products on Amazon. This strategic move aims to tap into the booming health and wellness market, with a focus on organic and kosher offerings like Pain Relief Cream and Anxiety Tinctures. The CEO, Lisa Nelson, projects significant revenue growth from this venture, leveraging the competitive advantage of their certified products. Additionally, the company is exploring opportunities in Arizona's recreational cannabis market, enhancing its growth potential and product distribution.
CBD Life Sciences (OTC PINK:CBDL) announced a Letter of Understanding regarding a lease for a hemp farm in Arizona through its subsidiary, LBC Bioscience Inc. The agreement is expected to be finalized within a week, enhancing the company's revenue and production capabilities. CEO Lisa Nelson highlighted the potential for growth and increased product exposure. LBC already offers a wide array of CBD products, including bath bombs and oils, with upcoming holiday sales and promotions. The hemp industry boasts over 25,000 uses, presenting significant growth opportunities for the company.
CBD Life Sciences (OTC PINK: CBDL) announced the launch of new CBD Flower products through its subsidiary, LBC Bioscience Inc. The two strains introduced are Hawaiian Haze, recognized for its tropical flavor profile, and Sour Space Candy, noted for its unique candied apple taste. These products promise various health benefits, including support for neurological and behavioral conditions, pain management, and gastrointestinal disorders. With ongoing holiday promotions and a broad product line, LBC aims to enhance customer engagement and sales.
CBD Life Sciences Inc. (OTC PINK:CBDL) announces the launch of new 100 MG CBD Bath Bombs, available in six colors and scents. These bath bombs contain 100mg of pure CBD Isolate, enriched with essential oils and minerals designed to promote relaxation, relieve stress and pain, and enhance overall health. The products are crafted by LBC Bioscience, ensuring high quality through certified GMP standards and third-party testing. The bath bombs are now available for purchase, with additional seasonal scents expected soon.